y (Nirsevimab) RSV-mAb Beyfortus
Vaccine Abbreviation(s) Trade name(s)
COVID-19 vaccine 1vCOV-mRNA Comirnaty/Pfizer-BioNTech
COVID-19 Vaccine
Spikevax/Moderna
COVID-19 Vaccine
1vCOV-aPS Novavax COVID-19 Vaccine
Dengue vaccine DEN4CYD Dengvaxia
Diphtheria, tetanus, and acellular pertussis vaccine DTaP Daptacel
Infanrix
Haemophilus influenzae type b vaccine Hib (PRP-T)
Hib (PRP-OMP)
ActHIB
Hiberix
PedvaxHIB
Hepatitis A vaccine HepA Havrix
Vaqta
Hepatitis B vaccine HepB Engerix-B
Recombivax HB
Human papillomavirus vaccine HPV Gardasil 9
Influenza vaccine (inactivated: egg-based) IIV3 Multiple
Influenza vaccine (inactivated: cell-culture) ccIIV3 Flucelvax
Influenza vaccine (live, attenuated) LAIV3 FluMist
Measles, mumps, and rubella vaccine MMR M-M-R II
Priorix
Meningococcal serogroups A, C, W, Y vaccine MenACWY-CRM Menveo
MenACWY-TT MenQuadfi
Meningococcal serogroup B vaccine MenB-4C Bexsero
MenB-FHbp Trumenba
Meningococcal serogroup A, B, C, W, Y vaccine MenACWY-TT/
MenB-FHbp
Penbraya
Mpox vaccine Mpox Jynneos
Pneumococcal conjugate vaccine PCV15
PCV20
Vaxneuvance
Prevnar 20
Pneumococcal polysaccharide vaccine PPSV23 Pneumovax 23
Poliovirus vaccine (inactivated) IPV Ipol
Respiratory syncytial virus vaccine RSV Abrysvo
Rotavirus vaccine RV1
RV5
Rotarix
RotaTeq
Tetanus, diphtheria, and acellular pertussis vaccine Tdap Adacel
Boostrix
Tetanus and diphtheria vaccine Td Tenivac
Tdvax
Varicella vaccine VAR Varivax
Combination vaccines (use combination vaccines instead of separate injections when appropriate)
DTaP, hepatitis B, and inactivated poliovirus vaccine DTaP-HepB-IPV Pediarix
DTaP, inactivated poliovirus, and Haemophilus influenzae type b vaccine DTaP-IPV/Hib Pentacel
DTaP and inactivated poliovirus vaccine DTaP-IPV Kinrix
Quadracel
DTaP, inactivated poliovirus, Haemophilus influenzae type b, and
hepatitis B vaccine
DTaP-IPV-HibHepB
Vaxelis
Measles, mumps, rubella, and varicella vaccine MMRV ProQuad
*Administer recommended vaccines if immunization history is incomplete or unknown. Do not restart or add doses to vaccine series for
extended intervals between doses. When a vaccine is not administered at the recommended age, administer at a subsequent visit.
The use of trade names is for identification purposes only and does not imply endorsement by the ACIP or CDC.
Report
y
y
Suspected cases of reportable vaccine-preventable diseases or outbreaks to your state or local health
department
Clinically significant adverse events to the Vaccine Adverse Event Reporting System (VAERS) at
www.vaers.hhs.gov or 800-822-7967
Questions or comments
Contact www.cdc.gov/cdc-info or 800-CDC-INFO (800-232-4636), in English or Spanish, 8 a.m.–8 p.m. ET,
Monday through Friday, excluding holidays.
Download the CDC Vaccine Schedules app for providers at
www.cdc.gov/vaccines/hcp/imz-schedules/app.html
Helpful information
Complete Advisory Committee on Immunization Practices (ACIP) recommendations:
www.cdc.gov/acip-recs/hcp/vaccine-specific/index.html
ACIP Shared Clinical Decision-Making Recommendations:
www.cdc.gov/acip/vaccine-recommendations/shared-clinical-decision-making.html
General Best Practice Guidelines for Immunization (including contraindications and precautions):
www.cdc.gov/vaccines/hcp/acip-recs/general-recs/index.html
Vaccine information statements:
www.cdc.gov/vaccines/hcp/vis/index.html
Manual for the Surveillance of Vaccine-Preventable Diseases
(including case identification and outbreak response):
www.cdc.gov/surv-manual/php/
1
Determine
recommended
vaccine by age
(Table 1)
2
Determine
recommended
interval for catchup vaccination
(Table 2)
3
Assess need
for additional
recommended
vaccines
by medical
condition or
other indication
(Table 3)
4
Review
vaccine types,
frequencies,
intervals, and
considerations
for special
situations
(Notes)
5
Review
contraindications
and precautions
for vaccine types
(Appendix)
6
Review new or
updated ACIP
guidance
(Addendum)
11/21/2024
Scan QR code
for access to
online schedule
CS310020-E
R
5th dose
Haemophilus influenzae type b (Hib) 1st dose 2nd dose See Notes 3rdor 4th dose – (See Notes)–
Pneumococcal conjugate
(PCV15, PCV20) 1st dose 2nd dose 3rd dose —– 4th dose —–
Inactivated poliovirus (IPV) 1st dose 2nd dose —————————- 3rd dose —————————- 4th dose See
Notes
COVID-19 (1vCOV-mRNA, 1vCOV-aPS) 1 or more doses of 2024–2025 vaccine (See Notes)
Influenza (IIV3, ccIIV3) 1 or 2 doses annually 1 dose annually
Influenza (LAIV3) 1 or 2 doses
annually 1 dose annually
Measles, mumps, rubella (MMR) See Notes —– 1st dose —– 2nd dose
Varicella (VAR) —– 1st dose —– 2nd dose
Hepatitis A (HepA) See Notes 2-dose series (See Notes)
Tetanus, diphtheria, acellular pertussis
(Tdap ≥7 yrs) 1 dose
Human papillomavirus (HPV) See
Notes
Meningococcal (MenACWY-CRM ≥2 mos,
MenACWY-TT ≥2years) See Notes 1st dose 2nd dose
Meningococcal B
(MenB-4C, MenB-FHbp)
See Notes
Respiratory syncytial virus vaccine
(RSV [Abrysvo])
Seasonal administration
during pregnancy (See Notes)
Dengue (DEN4CYD: 9–16 yrs) Seropositive in endemic
dengue areas (See Notes)
Mpox
or or
Page 2
Range of recommended ages
for all children Range of recommended ages
for catch-up vaccination Range of recommended ages
for certain high-risk groups or
populations
Recommended vaccination can
begin in this age group Recommended vaccination based
on shared clinical decision-making No Guidance/
Not Applicable
T
nd RSV season 1 dose depending on maternal
RSV vaccination status (See Notes)
2nd RSV season for chronic
lung disease (See Notes)
1 dose depending on maternal
RSV vaccination status (See Notes)
Hepatitis B
Rotavirus SCIDb
DTaP/Tdap DTaP
Tdap: 1 dose each pregnancy
Hib See Notes See Notes HSCT: 3 doses
Pneumococcal
IPV
COVID-19 See Notes
Influenza
inactivated
Solid organ transplant:
18yrs (See Notes)
LAIV3 Asthma, wheezing: 2–4 yearsc
MMR *
VAR *
Hepatitis A
HPV * 3-dose series (See Notes)
MenACWY
MenB
RSV (Abrysvo) Seasonal administration
(See Notes)
Dengue
Mpox See Notes
Recommended for all ageeligible children who lack
documentation of a complete
vaccination series
Not recommended for all children,
but recommended for some
children based on increased risk for
or severe outcomes from disease
Recommended for all age-eligible
children, and additional doses may be
necessary based on medical condition
or other indications. See Notes.
Precaution: Might be
indicated if benefit of
protection outweighs
risk of adverse reaction
Contraindicated or not
recommended
*Vaccinate after pregnancy,
if indicated
No Guidance/
Not Applicable
T
low. Medical conditions are often not mutually exclusive. If multiple conditions are present, refer to guidance in all relevant
columns. See Notes for medical conditions not listed.
Vaccine
and other
immunizing
agents Pregnancy
Immunocompromised
(excluding HIV
infection)
HIV infection CD4
percentage and counta
CSF leak or
cochlear
implant
Asplenia or
persistent
complement
component
deficiencies
Heart disease or
chronic lung disease
Kidney failure,
End-stage
renal disease
or on dialysis
Chronic liver
disease Diabetes
<15% or
<200mm3
≥15% and
≥200mm3
RSV-mAb
(nirsevimab) 2nd RSV season 1 dose depending on maternal
RSV vaccination status (See Notes)
2nd RSV season for chronic
lung disease (See Notes)
1 dose depending on maternal
RSV vaccination status (See Notes)
Hepatitis B
Rotavirus SCIDb
DTaP/Tdap DTaP
Tdap: 1 dose each pregnancy
Hib See Notes See Notes HSCT: 3 doses
Pneumococcal
IPV
COVID-19 See Notes
Influenza
inactivated
Solid organ transplant:
18yrs (See Notes)
LAIV3 Asthma, wheezing: 2–4 yearsc
MMR *
VAR *
Hepatitis A
HPV * 3-dose series (See Notes)
MenACWY
MenB
RSV (Abrysvo) Seasonal administration
(See Notes)
Dengue
Mpox See Notes
Recommended for all ageeligible children who lack
documentation of a complete
vaccination series
Not recommended for all children,
but recommended for some
children based on increased risk for
or severe outcomes from disease
Recommended for all age-eligible
children, and additional doses may be
necessary based on medical condition
or other indications. See Notes.
Precaution: Might be
indicated if benefit of
protection outweighs
risk of adverse reaction
Contraindicated or not
recommended
*Vaccinate after pregnancy,
if indicated
No Guidance/
Not Applicable
T